Ryan White Care Hepatitis C & B Language
NATAP Webinar:
Friday 12:30pm ET - June 5th, 2026
Register:
Heart Health & HIV Prevention & Care in 2026 & Beyond
Watch Previous NATAP Webinars
Booklet:
ACHIEVING HEALTHY AGING Improving Health Outcomes Over 50
Current HIV Articles and News Updates
HIV
Hospitalization Rates and Associated Factors Among Older Adults With HIV in the United States
- (07/17/26)
Merck's LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
- (07/16/26)
Baseline and week 48 resistance analysis in participants receiving bictegravir + lenacapavir in the phase 2 ARTISTRY-1 study
- (07/10/26)
Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance–Associated Mutations or M184I/V in Proviral DNA
- (07/10/26)
Cognitive Aging and Brain Health A Comparison of Super Movers vs Nonsuper Movers
- (07/10/26)
Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk
- (07/10/26)
Mental health and HIV/AIDS the need for an integrated response
- (07/10/26)
Mental health and HIV/AIDS the need for an integrated response
- (07/10/26)
Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study
- (07/10/26)
Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study
- (07/10/26)
Mobile cognitive testing captures divergent longitudinal trajectories of verbal learning in adults with and without HIV
- (07/10/26)
Overall and cause-specific mortality and associated risk factors among middle-aged and older South Africans: findings from the health and ageing in Africa: a longitudinal study of an INDEPTH community in rural South Africa (HAALSI)
- (07/10/26)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
EASL:
Antisense oligonucleotide-based strategy to target hepatitis delta virus infections
- (06/15/26)
More Hep D Articles...
Aging & Perinatally Acquired HIV
EASL:
Senolytics dasatinib and quercetin reduce fibrosis in metabolic dysfunction-associated steatohepatitis: The Truth Study
- (06/12/26)
More Aging & HIV Articles...
PrEP
Liverpool PrEP Drug Interactions in Beta
- (07/15/26)
HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial
- (07/15/26)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status
- (07/10/26)
EASL:
Prevalence of Hepatitis B, and C in a Cohort of Transgender Women living with HIV or on PrEP
- (06/24/26)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
- (07/10/26)
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
- (07/10/26)
EASL:
Functional cure rate in chronic hepatitis B virus infected participants receiving elebsiran and pegylated interferon alfa: final results from the phase 2 ENSURE study (BRII-179)
- (07/10/26)
More Hep B Articles...
Fatty Liver, NAFLD, NASH, MASLD, MASH
EASL:
Sex-specific coronary calcification risk across MASLD and obesity phenotypes in rural Indian adults: reach rural India study
- (06/24/26)
EASL:
Central Obesity Is a Key Determinant of Advanced Fibrosis Across the Spectrum of Steatotic Liver Disease (SLD): A Population-Based Analysis
- (06/24/26)
EASL:
Real-world epidemiology and clinical outcomes in MASLD: A 20-year nationwide analysis of over 23 million individuals in Taiwan's National Health Insurance Research Database
- (06/24/26)
EASL:
Outcomes and all-cause mortality in people with MASLD in UK primary care: a real-world matched cohort study of 1.8 million individuals
- (06/24/26)
EASL:
Increased diagnosis and risk stratification for MASLD in primary care over the last 20 years: Real-world evidence from over 11.7 million individuals in the UK
- (06/24/26)
EASL:
MASLD in the WHO Africa region: prevalence and development of a simple score to detect advanced fibrosis in dysmetabolic patients
- (06/24/26)
EASL:
Prevalence of MASLD, MetALD, ALD and liver fibrosis in patients with type 2 diabetes in 30,199 subjects in the general population: insights from the LiverScreen cohort
- (06/24/26)
EASL:
Clinical Obesity Is Strongly Associated With Steatotic Liver Disease (SLD) and Advanced Fibrosis: Evidence From NHANES 2017-2018
- (06/24/26)
EASL:
Economic and healthcare resource burden of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a United States system dynamics model
- (06/24/26)
EASL:
Low treatment rates observed in an analysis of the chronic hepatitis B care cascade at a tertiary medical center in a major metropolitan area in the US
- (06/24/26)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
Conference List Here
https://www.croiconference.org/
https://academicmedicaleducation.com/programs/3rd-african-workshop-on-women-and-hiv-2026
https://academicmedicaleducation.com/programs/16th-international-workshop-on-women-and-hiv-2026
https://acthiv.org/
https://ddw.org/?doing_wp_cron=1768748258.8390960693359375000000
https://www.easlcongress.eu/
https://asm.org/events/asm-microbe/home
https://academicmedicaleducation.com/programs/24th-european-meeting-on-hiv-and-hepatitis-2026
https://www.iasociety.org/conferences/aids2026
https://academicmedicaleducation.com/programs?page=2
https://academicmedicaleducation.com/programs/27th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-and-other-antiviral-drugs-2026
2026 U.S. Conference on HIV/AIDS
Register to join us from September 17-20, 2026 in Anaheim, CA
Theme - United and Unbreakable: The HIV Movement at 45
https://www.nmac.org/uscha/
https://academicmedicaleducation.com/programs/9th-conference-on-liver-disease-in-africa-colda-2026
https://academicmedicaleducation.com/programs/17th-international-workshop-on-aging-and-hiv-2026
https://idweek.org/
https://aasld-igh.org/Home.aspx https://www.aasld.org/the-liver-meeting
https://hivglasgow.org/
